(1)
Jumayev , M. The Effects of Glucagon-Like Peptide-1 Agonist Therapy (Semaglutide and Tirzepatide) on Metabolic and Hormonal Parameters in Men With Obesity and Insulin Resistance. GSCMR 2026, 1 (2), 184-188. https://doi.org/10.5281/zenodo.18796264.